Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

.

Humana

(

HUM

) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.5%. By the end of trading, Humana rose 82 cents (1.2%) to $70.73 on average volume. Throughout the day, 2.6 million shares of Humana exchanged hands as compared to its average daily volume of 2.3 million shares. The stock ranged in a price between $69.60-$70.95 after having opened the day at $69.88 as compared to the previous trading day's close of $69.91. Other companies within the Health Care sector that increased today were:

MEI Pharma

(

MEIP

), up 22%,

BSD Medical Corporation

(

BSDM

), up 15.4%,

Arrhythmia Research Technology

(

HRT

), up 12.3%, and

MAKO Surgical Corporation

(

MAKO

), up 11.1%.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

Humana Inc. operates as a health care company that offers a range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. Humana has a market cap of $11.32 billion and is part of the

health services

industry. The company has a P/E ratio of 9.3, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are down 20.2% year to date as of the close of trading on Tuesday. Currently there are 14 analysts that rate Humana a buy, no analysts rate it a sell, and nine rate it a hold.

TheStreet Ratings rates Humana as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge!

Free download now

.

null